To further evaluate the effect of RBM24 on the stability of PTEN mRNA, CRC cells were treated with the transcriptional inhibitor actinomycin D and mRNA decay was assessed by qPCR analysis. The gene discussed is PTEN; the disease is colorectal carcinoma.